Search - tctmd.com

Displaying 261 - 280 of 327

Sort: Relevancy | Date

News Daily News

El Apixaban Superior a la Warfarin con independencia del Tipo y Duración de la FA

May 13, 2013

News Daily News

Apixaban Superior to Warfarin Regardless of A-fib Type, Duration

May 13, 2013

News Daily News

La ESC Ofrece Recomendaciones para el Uso de Nuevos Anticoagulantes Orales

Yael L. Maxwell

May 03, 2013

News Daily News

ESC Offers Recommendations on Use of New Oral Anticoagulants

Yael L. Maxwell

May 03, 2013

Presentation

Cost-Effectiveness of Apixaban, Dabigatran, Rivaroxaban, and Warfarin for Stroke Prevention in Atrial Fibrillation

Presenter: A.R. Harrington

April 05, 2013

News Daily News

Registro Danés: El Dabigatran es Seguro y Eficaz en el Mundo Real

Caitlin E. Cox

April 05, 2013

News Daily News

Danish Registry: Dabigatran Safe, Effective in Real-World Use

Caitlin E. Cox

April 05, 2013

Presentation

Efficacy and Safety of Dabigatran Etexilate vs. Warfarin in ‘Real-World’ Patients with A-Fib

Presenter: T.B. Larsen

March 29, 2013

News Daily News

Yet Another Novel Anticoagulant Shows Promise for Preventing Stroke in A-fib

March 28, 2013

News Daily News

Un Documento de la ESC Orienta sobre el Uso Doble de IBP y Antitrombóticos

Caitlin E. Cox

February 27, 2013

News Daily News

ESC Position Paper Offers Guidance on Dual PPI and Antithrombotic Use

Caitlin E. Cox

February 27, 2013

News Daily News

PROTECT AF: Longer Follow-up Provides Clarity on Watchman vs. Warfarin for A-fib

Caitlin E. Cox

January 30, 2013

News Daily News

PROTECT AF: El Seguimiento a Más Largo Plazo Aclara la Situación del Dispositivo Watchman frente a la Warfarina contra la FA

Caitlin E. Cox

January 30, 2013

News Conference News AHA 2012

Evidence Continues to Support Dabigatran Treatment in A-fib

November 06, 2012

News Conference News TCT 2012

Stroke Prevention Strategies Discussed

October 26, 2012

News Industry News

Boston Scientific Demonstrates Ongoing Structural Heart Advances at Transcatheter Cardiovascular Therapeutics 2012 in Miami

October 23, 2012

Presentation TCT 2012

When Triple Therapy Is Needed: Warfarin, Dabigatran, Rivaroxaban, and Cilostazol Considerations

Presenter: Harvey White

October 22, 2012

News Daily News

Una Nueva Clase de Anticoagulantes Orales resulta Segura comparada con la Warfarina para Pacientes con FA

October 19, 2012

News Daily News

New Class of Oral Anticoagulants Safer Compared with Warfarin for A-fib

October 19, 2012

News Daily News

Un Meta análisis estudia Nuevos Anticoagulantes + Terapia Doble en Pacientes que han sufrido un SCA

October 02, 2012

Advertisement

El Apixaban Superior a la Warfarin con independencia del Tipo y Duración de la FA

Apixaban Superior to Warfarin Regardless of A-fib Type, Duration

La ESC Ofrece Recomendaciones para el Uso de Nuevos Anticoagulantes Orales

ESC Offers Recommendations on Use of New Oral Anticoagulants

Cost-Effectiveness of Apixaban, Dabigatran, Rivaroxaban, and Warfarin for Stroke Prevention in Atrial Fibrillation

Registro Danés: El Dabigatran es Seguro y Eficaz en el Mundo Real

Danish Registry: Dabigatran Safe, Effective in Real-World Use

Efficacy and Safety of Dabigatran Etexilate vs. Warfarin in ‘Real-World’ Patients with A-Fib

Yet Another Novel Anticoagulant Shows Promise for Preventing Stroke in A-fib

Un Documento de la ESC Orienta sobre el Uso Doble de IBP y Antitrombóticos

ESC Position Paper Offers Guidance on Dual PPI and Antithrombotic Use

PROTECT AF: Longer Follow-up Provides Clarity on Watchman vs. Warfarin for A-fib

PROTECT AF: El Seguimiento a Más Largo Plazo Aclara la Situación del Dispositivo Watchman frente a la Warfarina contra la FA

Evidence Continues to Support Dabigatran Treatment in A-fib

Stroke Prevention Strategies Discussed

Boston Scientific Demonstrates Ongoing Structural Heart Advances at Transcatheter Cardiovascular Therapeutics 2012 in Miami

When Triple Therapy Is Needed: Warfarin, Dabigatran, Rivaroxaban, and Cilostazol Considerations

Una Nueva Clase de Anticoagulantes Orales resulta Segura comparada con la Warfarina para Pacientes con FA

New Class of Oral Anticoagulants Safer Compared with Warfarin for A-fib

Un Meta análisis estudia Nuevos Anticoagulantes + Terapia Doble en Pacientes que han sufrido un SCA

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content